But Alexander, of Johns Hopkins Bloomberg School of Public Health, says you often have other options
Dose Adjustment: Depending on the strength of the injection you were on, you may need to start at a specific tier of the oral medication to avoid withdrawal of the appetite suppression or sudden side effects
Clinical trials for orforglipron have shown encouraging results: Orforglipron: Approximately a 1.6% reduction in HbA1c and an 8% body weight reduction (~16 pounds) after 40 weeks, with no strict fasting or water-intake rules,
NICE Technology Appraisal (TA875) recommends semaglutide (Wegovy) only for adults with at least one weight-related comorbidity and a BMI 35 kg/m (or 32.5 kg/m for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean backgrounds)
Whilst Ozempic has demonstrated significant efficacy in glycaemic control and weight reduction, it is associated with a range of gastrointestinal adverse effects
How retatrutide targets multiple metabolic pathways Retatrutide takes the opposite approach